Meanwhile, tumor‐infiltrating CD11c+ DCs, CD4+ T cells, and CD8+ T cells were also upregulated following PRMT5i treatment combined with CPT‐11 (Figure 7L–O). This evidence concerns the gene ITGAX and neoplasm.